Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18678578rdf:typepubmed:Citationlld:pubmed
pubmed-article:18678578lifeskim:mentionsumls-concept:C0003864lld:lifeskim
pubmed-article:18678578lifeskim:mentionsumls-concept:C0017337lld:lifeskim
pubmed-article:18678578lifeskim:mentionsumls-concept:C1456820lld:lifeskim
pubmed-article:18678578lifeskim:mentionsumls-concept:C0011209lld:lifeskim
pubmed-article:18678578lifeskim:mentionsumls-concept:C0036043lld:lifeskim
pubmed-article:18678578lifeskim:mentionsumls-concept:C0205276lld:lifeskim
pubmed-article:18678578lifeskim:mentionsumls-concept:C0205390lld:lifeskim
pubmed-article:18678578lifeskim:mentionsumls-concept:C0231491lld:lifeskim
pubmed-article:18678578lifeskim:mentionsumls-concept:C0086022lld:lifeskim
pubmed-article:18678578lifeskim:mentionsumls-concept:C0332256lld:lifeskim
pubmed-article:18678578lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:18678578lifeskim:mentionsumls-concept:C1705099lld:lifeskim
pubmed-article:18678578lifeskim:mentionsumls-concept:C0442335lld:lifeskim
pubmed-article:18678578pubmed:issue8lld:pubmed
pubmed-article:18678578pubmed:dateCreated2009-7-16lld:pubmed
pubmed-article:18678578pubmed:abstractTextTo examine the safety and tolerability of a single intra-articular injection of rAAV2-TNFR:Fc, an adenoassociated virus serotype 2 vector containing the cDNA for the human tumour necrosis factor-immunoglobulin Fc fusion gene (tgAAC94), in subjects with inflammatory arthritis.lld:pubmed
pubmed-article:18678578pubmed:languageenglld:pubmed
pubmed-article:18678578pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678578pubmed:citationSubsetIMlld:pubmed
pubmed-article:18678578pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678578pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678578pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678578pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678578pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678578pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18678578pubmed:statusMEDLINElld:pubmed
pubmed-article:18678578pubmed:monthAuglld:pubmed
pubmed-article:18678578pubmed:issn1468-2060lld:pubmed
pubmed-article:18678578pubmed:authorpubmed-author:FurstD EDElld:pubmed
pubmed-article:18678578pubmed:authorpubmed-author:ChalmersAAlld:pubmed
pubmed-article:18678578pubmed:authorpubmed-author:KeystoneEElld:pubmed
pubmed-article:18678578pubmed:authorpubmed-author:AnklesariaPPlld:pubmed
pubmed-article:18678578pubmed:authorpubmed-author:HobbsKKlld:pubmed
pubmed-article:18678578pubmed:authorpubmed-author:MeaseP JPJlld:pubmed
pubmed-article:18678578pubmed:authorpubmed-author:HealdA EAElld:pubmed
pubmed-article:18678578pubmed:authorpubmed-author:BookmanAAlld:pubmed
pubmed-article:18678578pubmed:authorpubmed-author:El-GabalawyHHlld:pubmed
pubmed-article:18678578pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18678578pubmed:volume68lld:pubmed
pubmed-article:18678578pubmed:ownerNLMlld:pubmed
pubmed-article:18678578pubmed:authorsCompleteYlld:pubmed
pubmed-article:18678578pubmed:pagination1247-54lld:pubmed
pubmed-article:18678578pubmed:dateRevised2009-10-1lld:pubmed
pubmed-article:18678578pubmed:meshHeadingpubmed-meshheading:18678578...lld:pubmed
pubmed-article:18678578pubmed:meshHeadingpubmed-meshheading:18678578...lld:pubmed
pubmed-article:18678578pubmed:meshHeadingpubmed-meshheading:18678578...lld:pubmed
pubmed-article:18678578pubmed:meshHeadingpubmed-meshheading:18678578...lld:pubmed
pubmed-article:18678578pubmed:meshHeadingpubmed-meshheading:18678578...lld:pubmed
pubmed-article:18678578pubmed:meshHeadingpubmed-meshheading:18678578...lld:pubmed
pubmed-article:18678578pubmed:meshHeadingpubmed-meshheading:18678578...lld:pubmed
pubmed-article:18678578pubmed:meshHeadingpubmed-meshheading:18678578...lld:pubmed
pubmed-article:18678578pubmed:meshHeadingpubmed-meshheading:18678578...lld:pubmed
pubmed-article:18678578pubmed:meshHeadingpubmed-meshheading:18678578...lld:pubmed
pubmed-article:18678578pubmed:meshHeadingpubmed-meshheading:18678578...lld:pubmed
pubmed-article:18678578pubmed:meshHeadingpubmed-meshheading:18678578...lld:pubmed
pubmed-article:18678578pubmed:meshHeadingpubmed-meshheading:18678578...lld:pubmed
pubmed-article:18678578pubmed:meshHeadingpubmed-meshheading:18678578...lld:pubmed
pubmed-article:18678578pubmed:meshHeadingpubmed-meshheading:18678578...lld:pubmed
pubmed-article:18678578pubmed:meshHeadingpubmed-meshheading:18678578...lld:pubmed
pubmed-article:18678578pubmed:meshHeadingpubmed-meshheading:18678578...lld:pubmed
pubmed-article:18678578pubmed:meshHeadingpubmed-meshheading:18678578...lld:pubmed
pubmed-article:18678578pubmed:meshHeadingpubmed-meshheading:18678578...lld:pubmed
pubmed-article:18678578pubmed:meshHeadingpubmed-meshheading:18678578...lld:pubmed
pubmed-article:18678578pubmed:meshHeadingpubmed-meshheading:18678578...lld:pubmed
pubmed-article:18678578pubmed:year2009lld:pubmed
pubmed-article:18678578pubmed:articleTitleLocal delivery of a recombinant adenoassociated vector containing a tumour necrosis factor alpha antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study.lld:pubmed
pubmed-article:18678578pubmed:affiliationSeattle Rheumatology Associates/Swedish Medical Center Research, Seattle, Washington, USA.lld:pubmed
pubmed-article:18678578pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18678578pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:18678578pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:18678578pubmed:publicationTypeClinical Trial, Phase Illd:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18678578lld:pubmed